Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Thc2.5
Tetrahydrocurcumin – Forschung
Überwiegend Mechanismus / Beobachtung
20 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu Tetrahydrocurcumin sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus mittelwertigen randomisierten Studien, veröffentlicht 2006–2026 mit einer typischen Studiengröße von 19 Teilnehmenden.
Basierend auf 20 Studien · 1 RCT · 29 Teilnehmende insgesamt
Konfidenz
Geringe Konfidenz
Nach Outcome
Neuroprotection & brain agingNeuroprotective and mood signals come from animal studies and one 19-person adjunct pilot; not established · Unknown
Überwiegend Mechanismus / Beobachtung4 Studien
Cognitive function
Zu wenige bewertete Studien2 Studien
Depression & mood
Zu wenige bewertete Studien2 Studien
Glucose & metabolic
Zu wenige bewertete Studien2 Studien
InflammationAnti-inflammatory activity is consistent in preclinical models; human anti-inflammatory benefit is unproven · Unknown (no human dosing data)
Zu wenige bewertete Studien2 Studien
Therapeutic & clinical
Zu wenige bewertete Studien2 Studien
Weight management
Zu wenige bewertete Studien2 Studien
Energy & fatigue
Zu wenige bewertete Studien1 Studie
2 weitere Outcomes mit weniger Studien nicht angezeigt.
Aktives Forschungsgebiet
15 Studien in den letzten 5 Jahren
200620162026
1Übersicht2025
Einfach gesagt: Thus, curcumin holds promise as a multifaceted agent in the management of obesity and associated diseases.
Cerullo M, Armeli F, Mengoni B, Menin M, Crudeli ML, Businaro R. · Nutrients (2025)
Additionally, curcumin modulates oxidative stress by activating the NRF2 pathway, enhancing cellular antioxidant defenses.
Emerging evidence also supports curcumin's potential in improving gut health by modulating microbiota composition, enhancing intestinal barrier function, and reducing systemic inflammation.
This interaction with the gut-brain axis highlights the broader implications of curcumin in neuroprotection, as it positively affects cognitive function and mitigates neuroinflammation in neurodegenerative diseases like Alzheimer's. disease.
Einfach gesagt: Research on THC's therapeutic application must focus on improving delivery and bioavailability and confirming its clinical safety and efficacy.
Zeng A, Quan Y, Tao H, Dai Y, Song L, Zhao J, Zhao J. · International journal of molecular sciences (2025)
Tetrahydrocurcumin (THC), a curcumin derivative, shows potential in oncology and neurology.
It regulates NF-κB, reduces inflammation, promotes cancer cell apoptosis, inhibits tumor angiogenesis, and enhances antioxidants, aiding in treating inflammation-related cancers.
In neurology, THC's anti-inflammatory and antioxidant properties protect neurons, reduce neuroinflammation, and support autophagy for cellular debris clearance, with its blood-brain barrier penetration offering a neuroprotective edge.
Einfach gesagt: As a major active metabolite of curcumin, tetrahydrocurcumin had a wide range of biological activities and significant treatment effects on diseases [in preclinical studies].
Zhou M et al. · Food & Function (2024)
Comprehensive review of THC's preclinical activity across neurological disorders, metabolic syndrome, cancers, and inflammatory diseases.
Effects are mediated by MAPK, JAK/STAT, NF-κB, Nrf2, PI3K/Akt/mTOR, AMPK, and Wnt/β-catenin signalling.
Frames THC as a compound still under development for dietary supplements and drugs — i.e. not yet clinically established.
Einfach gesagt: Various studies suggest that curcumin is a more potent antioxidant than THC.
Aggarwal BB et al. · Molecules (2014)
Mechanistic review directly comparing curcumin and its metabolite THC.
Best counter-evidence: curcumin (not THC) binds and inhibits many targets and is more effective at suppressing tumour-cell growth and viral entry; THC is superior only for select actions (e.g. glutathione peroxidase induction).
Undercuts the marketing premise that THC is simply a stronger, more bioavailable curcumin.
Einfach gesagt: Curcumin metabolites exhibit activity comparable to, or even exceeding, the therapeutic potential of the parent compound in models of glucose and lipid metabolism.
Liu F et al. · The American Journal of Chinese Medicine (2026)
Systematic review of curcumin's reduced metabolites — including tetrahydrocurcumin — and their regulation of glucose and lipid homeostasis via PPARα, NF-κB, and PI3K/AKT.
Argues part of curcumin's metabolic activity may be mediated by metabolites like THC, which overcome curcumin's poor bioavailability.
Review-level and largely preclinical; no THC-specific human metabolic trial exists.
Einfach gesagt: This work could enhance our understanding toward health-promoting properties of spice compounds as well as provide new insights into the prevention and treatment of disorders associated with mitochondrial dysfunctions by those nutraceuticals.
Han L, Ho CT, Lu M. · Journal of agricultural and food chemistry (2025)
In this review, the role of mitochondria in maintaining cellular and metabolism homeostasis is summarized.
The regulatory effects of mitochondrial function by major bioactive compounds from natural spices are evaluated, including capsaicin, 6-gingerol, 6-shogaol, allicin, quercetin, curcumin, tetrahydrocurcumin, and cinnamaldehyde.
The underlying molecular mechanisms are also discussed.
Einfach gesagt: This review comprehensively analyses the application of TCM in AMS and makes suggestions for more in-depth studies in the future, aiming to provide some ideas and insights for subsequent studies.
Wu Z, Wang Y, Gao R, Chen J, Chen Y, Li M, Gao Y. · Frontiers in pharmacology (2024)
Conclusion The main pathogenesis of AMS is unclear.
Still, TCM formulas and components have been used to treat AMS through multifaceted interventions, such as compound danshen drip pills, Huangqi Baihe granules, salidroside, and ginsenoside Rg1.
This review comprehensively analyses the application of TCM in AMS and makes suggestions for more in-depth studies in the future, aiming to provide some ideas and insights for subsequent studies.
Einfach gesagt: Taken together, curcumin and its next-generation derivatives may offer a novel therapeutic approach to intervene in the adipose tissue-gut-liver axis for the treatment of obesity-related metabolic diseases.
Konaktchieva M, Stojchevski R, Hadzi-Petrushev N, Gagov H, Konakchieva R, Mitrokhin V, Kungulovski G, Mladenov M, Avtanski D. · Pharmaceuticals (Basel, Switzerland) (2025)
Pilot and randomized clinical trials suggest that curcumin supplementation enhances glucose and lipid metabolism, reduces liver fat content, and modulates inflammatory markers; however, results across studies remain heterogeneous.
Large, high-quality multicenter trials using rigorously standardized, bioavailable curcumin formulations are still required to reliably establish the efficacy and safety of curcumin in metabolic diseases.
Next steps involve comparing curcumin analogs, conducting multi-omics analyses to understand host-microbiota-organ crosstalk, and determining cooperative approaches with lifestyle and pharmacological interventions.
Einfach gesagt: Building on existing research, future research should focus on large-scale clinical trials and advanced multi-omics studies to uncover the potential of TCM in managing T2DM through the gut microbiota.
Bibi A, Zhou L, You M, Niu H, Tasleem MW, Wu H, Zhang H. · The American journal of Chinese medicine (2026)
It also discusses the therapeutic potential of TCM, which includes natural medicinal extracts like baicalin, berberine, tetrahydrocurcumin, ginsenoside Rb1, ophiopogonin D, and resveratrol, compound formulations, and acupuncture, in regulating the intestinal microbiota ecosystem to manage T2DM.
Although the current evidence suggests that these interventions may slow T2DM progression, most studies have been confined to animal models and early clinical trials which lack adequate clinical evidence to confirm their efficacy.
This discrepancy has created an imbalance between theoretical and validated clinical applications.
Einfach gesagt: This work highlights the need for carefully designed, long-term studies to better understand how curcumin and its bioactive metabolites work, their safety, and their effectiveness.
Lagoa R, Rajan L, Violante C, Babiaka SB, Marques-da-Silva D, Kapoor B, Reis F, Atanasov AG. · Biotechnology advances (2025)
Furthermore, the exploration of drug-laden scaffolds and dermal delivery may extend the pharmacological applications of curcumin.
Recent advancements in delivery systems, particularly brain-targeting nanocarriers like polymersomes, micelles, and liposomes, have shown promise in enhancing curcumin's bioavailability and therapeutic efficacy in animal models.
Studies reviewed here indicate that engineered dermal formulations and devices could serve as viable alternatives for neuroprotective treatments and to manage skin or musculoskeletal inflammation.
Einfach gesagt: THC ameliorated nonalcoholic steatohepatitis induced by high-fat diet by restoring hepatocyte lipophagy through the mTORC1-TFEB signaling pathway.
Wu J et al. · Biomedicine & Pharmacotherapy (2024)
Rat NASH model plus a palmitate-stimulated cell model: THC improved liver function, lipid metabolism, inflammation, and oxidative stress by restoring lipophagy.
Preclinical liver/metabolic evidence — not yet tested in humans.
Einfach gesagt: THC significantly attenuated agonist-induced granule secretion in human gel-filtered platelets in vitro ... leading to a decrease in thromboxane A2 generation.
Li W et al. · Thrombosis and Haemostasis (2022)
In-vitro study on human platelets plus an in-vivo thrombosis model: THC inhibited platelet granule secretion and thromboxane A2 via cPLA2/MAPK signalling.
Mechanistic basis for THC's antiplatelet/antithrombotic potential — and the reason for caution when combining it with anticoagulant or antiplatelet drugs.
Einfach gesagt: THC administration rescued learning and memory, and reduced Aβ burden in the hippocampus of APP/PS1 mice.
Xiao Y et al. · Biomedicine & Pharmacotherapy (2021)
Alzheimer mouse model plus BV-2 microglial cells: THC rescued learning and memory and reduced amyloid-β burden via anti-inflammatory and anti-apoptotic pathways.
Underpins the neuroprotection signal — but this is animal evidence; the only human neuro data is the 19-person depression pilot.
Einfach gesagt: Tetrahydrocurcumin ... resulted a significant reduction in blood glucose and significant increase in plasma insulin in diabetic rats, which proved its antidiabetic effect.
Murugan P, Pari L. · Basic & Clinical Pharmacology & Toxicology (2006)
Diabetic-rat study: oral THC (80 mg/kg, 45 days) lowered blood glucose, raised insulin, and reduced lipid peroxidation and serum/tissue lipids.
A foundational metabolic/antidiabetic preclinical study; the paper notes THC outperformed curcumin on some markers.
Einfach gesagt: A randomized, open-label, parallel-group pilot trial enrolled 19 patients with major depressive disorder who received either escitalopram or escitalopram plus tetrahydrocurcumin for 29 days.
Guo Y et al. · Molecular Neurobiology (2025)
Small (n=19) randomized, open-label pilot adding 200 mg/day THC to escitalopram for major depressive disorder.
Reported greater improvement in depression scores with the THC add-on, alongside anti-inflammatory mechanistic findings.
Too small and unblinded to establish efficacy — hypothesis-generating only.